395 related articles for article (PubMed ID: 22344232)
1. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
Yang L; Francois F; Pei Z
Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
Yang L; Lu X; Nossa CW; Francois F; Peek RM; Pei Z
Gastroenterology; 2009 Aug; 137(2):588-97. PubMed ID: 19394334
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
Snider EJ; Freedberg DE; Abrams JA
Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
6. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.
Taddei A; Fabbroni V; Pini A; Lucarini L; Ringressi MN; Fantappiè O; Bani D; Messerini L; Masini E; Bechi P
Dig Dis Sci; 2014 May; 59(5):949-57. PubMed ID: 24357184
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
9. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.
Verbeek RE; Siersema PD; Ten Kate FJ; Fluiter K; Souza RF; Vleggaar FP; Bus P; van Baal JW
J Gastroenterol; 2014 Jul; 49(7):1121-34. PubMed ID: 23955118
[TBL] [Abstract][Full Text] [Related]
11. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
Wang RH
World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
[TBL] [Abstract][Full Text] [Related]
12. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG; Whitaker A; Pei Z
Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
[TBL] [Abstract][Full Text] [Related]
13. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma].
Ren CR; Dong L; Guo XY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182
[TBL] [Abstract][Full Text] [Related]
14. The role of mucin in GERD and its complications.
Niv Y; Fass R
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):55-9. PubMed ID: 22064520
[TBL] [Abstract][Full Text] [Related]
15. The Esophageal Microbiome in Health and Disease.
Corning B; Copland AP; Frye JW
Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
[TBL] [Abstract][Full Text] [Related]
16. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
Lee JS; Oh TY; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Kim HJ; Hahm KB
Mutat Res; 2001 Sep; 480-481():189-200. PubMed ID: 11506813
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
18. Esophageal adenocarcinoma arising in Barrett esophagus.
Zhang HY; Spechler SJ; Souza RF
Cancer Lett; 2009 Mar; 275(2):170-7. PubMed ID: 18703277
[TBL] [Abstract][Full Text] [Related]
19. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus.
Spechler SJ
J Clin Gastroenterol; 2003; 36(5 Suppl):S2-5; discussion S26-8. PubMed ID: 12702959
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of gastroesophageal reflux and Barrett esophagus].
von Schrenck T
Zentralbl Chir; 2000; 125(5):414-23. PubMed ID: 10929625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
